Home|Journals|Articles by Year|Audio Abstracts

Original Article

Quality by design approach implementation in media development for the production of therapeutic enzyme

Tharaka Rama Velisetty, Sathish Thadikamala, Chiranjeevi Potu, Sudhakar Poda, Krishna Satya Alapati.


L-asparaginase is a highly demanding therapeutic enzyme. This enzyme has wide applications in food, therapeutic, and biosensor industries. Since L-asparaginase is a chemotherapeutic agent/enzyme, it is important to maintain the final product quality. Nowadays, FDA and other regulatory authorities emphasize having quality by design (QbD) based product development. Because of this requirement, QbD principles were implemented in this study for optimization of the L-asparaginase production by Bacillus subtilis THARAKA. QbD was implemented through the design of the experiment strategy. Initially, the Plackett–Burman design (PBD) was used to screen the nutrients which have a significant effect on the enzyme. Among 11 studied nutrients, 3 components glucose, L-asparagine, and (NH4)2SO4 were screened by using PBD, and their concentrations were further optimized by using response surface methodology. Screened nutrients and process parameters were optimized using the central composite design (CCD). By sequential optimization methods such as PBD followed by CCD a 28% L-asparaginase production was enhanced.

Key words: L-Asparaginase, Quality by Design (QbD), Plackett–Burman design (PBD), central composite design (CCD), Enzyme, Bacillus subtilis

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.